Skip to content
10-Q

Quarterly Report

Kestra Medical Technologies, Ltd. KMTS

0001193125-26-111205

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Mar 12, 2026 58.37M sh
Shares Diluted Q3 2026 · Jan 31, 2026 55.85M sh
Shares Diluted Q3 2026 · Jan 31, 2026 52.84M sh
Shares Diluted Q3 2026 · Jan 31, 2025 19.89M sh
Shares Diluted Q3 2026 · Jan 31, 2025 19.89M sh
Capex Q3 2026 · Jan 31, 2026 $25.23M
Capex Q3 2026 · Jan 31, 2025 $15.55M
Operating Cash Flow Q3 2026 · Jan 31, 2026 −$62.98M
Operating Cash Flow Q3 2026 · Jan 31, 2025 −$53.55M
Long Term Debt Q3 2026 · Jan 31, 2026 $42.26M
Long Term Debt Q3 2026 · Apr 30, 2025 $41.1M
Cash And Equivalents Q3 2026 · Jan 31, 2026 $291.32M
Cash And Equivalents Q3 2026 · Apr 30, 2025 $237.6M
Cash And Equivalents Q3 2026 · Jan 31, 2025 $54.35M
Stockholders Equity Q3 2026 · Jan 31, 2026 $287.99M
Stockholders Equity Q3 2026 · Oct 31, 2025 $164.08M
Stockholders Equity Q3 2026 · Jul 31, 2025 $184.16M
Stockholders Equity Q3 2026 · Apr 30, 2025 $205.41M
Stockholders Equity Q3 2026 · Jan 31, 2025 −$257.9M
Stockholders Equity Q3 2026 · Oct 31, 2024 −$236.55M
Stockholders Equity Q3 2026 · Jul 31, 2024 −$216.47M
Stockholders Equity Q3 2026 · Apr 30, 2024 −$209.38M
Current Liabilities Q3 2026 · Jan 31, 2026 $42.93M
Current Liabilities Q3 2026 · Apr 30, 2025 $37.98M
Total Liabilities Q3 2026 · Jan 31, 2026 $91.35M
Total Liabilities Q3 2026 · Apr 30, 2025 $90.34M
Current Assets Q3 2026 · Jan 31, 2026 $314.06M
Current Assets Q3 2026 · Apr 30, 2025 $255.33M
Total Assets Q3 2026 · Jan 31, 2026 $379.34M
Total Assets Q3 2026 · Apr 30, 2025 $295.74M
Eps Diluted Q3 2026 · Jan 31, 2026 −$0.61
Eps Diluted Q3 2026 · Jan 31, 2026 −$1.76
Eps Diluted Q3 2026 · Jan 31, 2025 −$1.25
Eps Diluted Q3 2026 · Jan 31, 2025 −$3.56
Eps Basic Q3 2026 · Jan 31, 2026 −$0.61
Eps Basic Q3 2026 · Jan 31, 2026 −$1.76
Eps Basic Q3 2026 · Jan 31, 2025 −$1.25
Eps Basic Q3 2026 · Jan 31, 2025 −$3.56
Sga Expense Q3 2026 · Jan 31, 2026 $42.7M
Sga Expense Q3 2026 · Jan 31, 2026 $114.73M
Sga Expense Q3 2026 · Jan 31, 2025 $23.8M
Sga Expense Q3 2026 · Jan 31, 2025 $64.48M
Rd Expense Q3 2026 · Jan 31, 2026 $4.97M
Rd Expense Q3 2026 · Jan 31, 2026 $13.85M
Rd Expense Q3 2026 · Jan 31, 2025 $3.35M
Rd Expense Q3 2026 · Jan 31, 2025 $10.27M
Net Income Q3 2026 · Jan 31, 2026 −$34.17M
Net Income Q3 2026 · Jan 31, 2026 −$92.78M
Net Income Q3 2026 · Jan 31, 2025 −$21.51M
Net Income Q3 2026 · Jan 31, 2025 −$61.76M
Operating Income Q3 2026 · Jan 31, 2026 −$34.77M
Operating Income Q3 2026 · Jan 31, 2026 −$95.4M
Operating Income Q3 2026 · Jan 31, 2025 −$20.6M
Operating Income Q3 2026 · Jan 31, 2025 −$58.17M
Gross Profit Q3 2026 · Jan 31, 2026 $12.91M
Gross Profit Q3 2026 · Jan 31, 2026 $33.18M
Gross Profit Q3 2026 · Jan 31, 2025 $6.55M
Gross Profit Q3 2026 · Jan 31, 2025 $16.58M
Cost Of Revenue Q3 2026 · Jan 31, 2026 $11.65M
Cost Of Revenue Q3 2026 · Jan 31, 2026 $33.31M
Cost Of Revenue Q3 2026 · Jan 31, 2025 $8.54M
Cost Of Revenue Q3 2026 · Jan 31, 2025 $26.01M
Revenue Q3 2026 · Jan 31, 2026 $24.55M
Revenue Q3 2026 · Jan 31, 2026 $66.49M
Revenue Q3 2026 · Jan 31, 2025 $15.09M
Revenue Q3 2026 · Jan 31, 2025 $42.58M